The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Low Grade Chronic Inflammation in Women with Polycystic Ovarian Syndrome
Abstract
Low grade chronic inflammation as reflected by increased C-reactive protein (CRP) concentrations independently predicts those at risk for coronary heart disease (CHD) and type 2 diabetes. Women with polycystic ovarian syndrome (PCOS) are insulin resistant and have increased risk for CHD and type 2 diabetes, but currently there are no data on markers of inflammation in women with PCOS. Seventeen women with PCOS (defined on the basis of elevated testosterone and oligomenorrhea) and 15 healthy women matched as a group for body mass index were recruited. Measurement of CRP concentrations was made using a highly sensitive assay. Insulin resistance was assessed using the hyperinsulinemic euglycemic clamp technique. The women with PCOS had significantly elevated CRP concentrations relative to controls (geometric means, 2.12 and 0.67 mg/L, respectively; P = 0.016). Log CRP correlated with body mass index in both PCOS and controls (r = 0.58; P < 0.05 and r = 0.78; P < 0.01, respectively) and inversely with insulin sensitivity (r = -0.57; P < 0.05 and r = -0.69; P < 0.01). Total testosterone did not correlate with log CRP in either group. On adjustment for body mass index and age, there remained a significant difference in log CRP between PCOS and controls (t = 2.13; P < 0.05). On further adjustment for insulin sensitivity, log CRP was no longer significantly different between groups (t = 1.51; P = 0.14). We conclude that women with PCOS have significantly increased CRP concentrations relative to women with normal menstrual rhythm and normal androgen levels. We propose low grade chronic inflammation as a novel mechanism contributing to increased risk of CHD and type 2 diabetes in these women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CRP and PAI-1 are reliable markers of inflammation and sensitive predictors of cardiovascular morbidity.57”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,366
Köenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,944
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Production of C-reactive protein and risk of coronary events in stable and unstable angina
Haverkate, E., Thompson, S. G., Pyke, S., Gallimore, J. R., & Mark B Pepys Group (1997) · The Lancet · doi:10.1016/s0140-6736(96)07591-5 · Cited by 1,511
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 638
Yüce, E., Pabuçcu, R., Keskin, M., Arslanca, T., & Pabuçcu, E. (2020) · Türk Üreme Tıbbı ve Cerrahisi Dergisi · doi:10.24074/tjrms.2020-80616 · Cited by 4
Diagnosis, Pathogenesis and Management of Polycystic Ovary Syndrome
Wang, F., & Wang, Z. (2017) · InTech eBooks · doi:10.5772/67877 · Cited by 4
Diamanti‐Kandarakis, E. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_32 · Cited by 4
Polycystic Ovary Syndrome, Inflammation, and Statins: Do We Have the Right Target?
Hoeger, K. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2376 · Cited by 4
Jin, Y., Hu, H., Zhang, J.-C., Xin, X., Zhu, Y., Zhang, H., Fan, R., Yang, Y., & Li, D. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2405098 · Cited by 3
Banerjee, A. A., & Banerjee, A. G. (2024) · International Journal of Translational Medical Research and Public Health · doi:10.25259/ijtmrph_20_2024 · Cited by 3
Role of hyperinsulinemic insulin resistance in polycystic ovary syndrome
Iuorno, M. J. (2001) · Polycystic Ovary Syndrome · doi:10.1017/cbo9780511545191.013 · Cited by 3
Rajaeieh, G., Mashhadi, N. S., Safavi, M., Pozveh, Z. A., & Pezeshki, A. (2018) · Nutrition and Food Sciences Research · doi:10.29252/nfsr.5.2.11 · Cited by 3
Can, M., Duran, C., Güney, İ., Elmas, H., Ayhan, M. E., & Erdem, S. S. (2020) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2020.04.002 · Cited by 3
Евгеньевна, Ч. Г., & Алексеевна, П. В. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-087 · Cited by 3
Gupte, P. A., Khade, K., Wagh, G. N., Deshmukh, C. S., Pandit, V. A., & Bhalerao, S. S. (2023) · Journal of Diabetology · doi:10.4103/jod.jod_17_23 · Cited by 3
Hosseini, S. F., Khodaei, F., Hasansagha, Z., Khosravizadeh, H., Abdollahi, M., & Azaryan, E. (2023) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.5812/jjnpp-137193 · Cited by 4
Yuk, J., Noh, J. H., Han, G. H., Yoon, S. H., & Kim, M. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70560 · Cited by 3
Bostancı, M. S., Bayram, M., Ciftci, F. C., Paşaoğlu, H., & Elbeğ, Ş. (2012) · Journal of Clinical and Experimental Investigations · doi:10.5799/ahinjs.01.2012.03.0169 · Cited by 3
Cobin, R. H. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.259 · Cited by 3
Jou, H., Hsu, I.-P., Ling, P., Lin, C.-T., Tsai, S.-T., Huang, H.-T., & Wu, S. (2006) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/s1028-4559(09)60227-8 · Cited by 3
Chronic Inflammation in Women with Polycystic Ovarian Syndrome
Üstüner, İ., Sönmezer, M., Atabekoğlu, C. S., Ergün, A., Güllü, S., & Aytaç, R. (2006) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Insulin Sensitizers Targeting Metabolic and Reproductive Consequences in Polycystic Ovary Syndrome
Diamanti‐Kandarakis, E. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_13 · Cited by 3
Sattar, N. A. (2011) · doi:10.1002/9781444347319.ch16 · Cited by 3
Hosseini, S. F., Khodaei, F., Hasansagha, Z., Khosravizadeh, H., Abdollahi, M., & Azaryan, E. (2023) · Preprints.org · doi:10.20944/preprints202304.0299.v1 · Cited by 3
Eswaran, U., Eswaran, V., Murali, K., & Eswaran, V. (2025) · Springer eBooks · doi:10.1007/978-981-96-2120-0_4 · Cited by 2
Sundharan, S., Dipnaik, K., Ingale, P., Shelke, S., & Rai, P. (2016) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20162925 · Cited by 2
Alam, F. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00015-3 · Cited by 2
Effect of Omega–3 Supplementation on Hormone Profile in Women with Poly Cystic Ovarian Syndrome
Pareek, M., & Boolchandani, R. (2020) · International Journal of Advanced Scientific Research and Management · doi:10.36282/ijasrm/5.9.2020.1754 · Cited by 2
Serum Adiponectin, TNF-α, IL-6 and Insulin Resistance in Women with Polycystic Ovary Syndrome
Kim, Y.-A., Noh, J.-H., Kim, D., Um, T. H., Cho, C. R., Jang, N.-Y., Kwon, S.-K., Lee, S.-H., Park, J.-H., Ko, K. S., et al. (2006) · The Journal of Korean Diabetes Association · doi:10.4093/jkda.2006.30.2.104 · Cited by 2
Pouyanmanesh, F., Nabiuni, M., Nasri, S., Nazari, Z., & Karimzadeh, L. (2013) · KAUMS Journal · Cited by 2
Studying levels of homocysteine in diagnosed cases of polycystic ovary syndrome
Sulaiman, D., & Suleiman, R. R. (2018) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_94_18 · Cited by 2
Das polyzystische Ovarsyndrom: Prototyp eines kardiometabolischen Syndroms
Heutling, D., Schulz, H., Randeva, H. S., Dodt, C., & Lehnert, H. (2007) · Der Internist · Cited by 2
Georgiev, T., & Kabakchieva, P. (2021) · Rheumatology (Bulgaria) · doi:10.35465/29.2.2021.pp40-51 · Cited by 2
CRP LEVELS AND ENDOTHELIAL FUNCTION IN YOUNG WOMEN WITH PCOS
Neelaveni, K., Menon, R., Sahay, R. K., & Chandrasekhara Reddy, G. (2016) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2016/1305 · Cited by 2
Cardiovascular Disease and Inflammation
Orio, F., Diamanti‐Kandarakis, E., & Palomba, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_13 · Cited by 2
Metabolic and cardiovascular risk in the polycystic ovary syndrome
Cussons, A. J., Stuckey, B. G. A., & Watts, G. F. (2005) · Practical Diabetes · doi:10.1002/pdi.839 · Cited by 2
Does Serum R-Spondin-1 Play a Role in PCOS Pathophysiology?
Başpınar, O., Şimşek, Y., Koçer, D., Dizdar, O. S., & TOPALOĞLU, H. K. (2022) · Genel Tıp Dergisi · doi:10.54005/geneltip.1111079 · Cited by 1
Çağlar, Y. A., & Taşkın, M. İ. (2024) · Medicina · doi:10.3390/medicina60122102 · Cited by 2
Gusain, N., Anjankar, A. P., & Ambad, R. S. (2025) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_1994_24 · Cited by 1
Polycystic ovary syndrome as a risk factor for cancer
Gambera, A., Rodondi, G., Oliveri, G., Ferrari, F. G., Vignali, M., Fichera, A., & Odicino, F. E. (2025) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.25.05719-7 · Cited by 1
Wen, J., Zhang, F., Cheng, G., Liu, C., & Zhang, Y. (2025) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2025.2555173 · Cited by 1
Biomarkers for effective prognosis of polycystic ovary syndrome: a full review
Singh, I., Pant, A., & Maurya, P. K. (2026) · Biomarkers in Medicine · doi:10.1080/17520363.2026.2622044 · Cited by 1
Zhang, Q., Li, H., Meng, Y., Zhao, W., Li, W., Dai, C., Li, B., Cheng, J., Yang, J., Hu, J. B., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70374 · Cited by 1
Gut microbiota in PCOS: key microbial changes, potential mechanisms and clinical applications
Shi, S., Ma, J., Jing, X., Jia, W., & Sun, X. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08352-2 · Cited by 2
Tijare, D. C., Arya, S., Loharkar, S., Jindal, A., Veerabomma, H., Dighe, V., Katyal, A., Chandra, R., & Madan, J. (2026) · BioNanoScience · doi:10.1007/s12668-026-02722-2 · Cited by 1
Metabolic and Endocrine Effects of Statins in Polycystic Ovary Syndrome
Kodaman, P. H., & Dulęba, A. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_15 · Cited by 1
C-reactive protein level and obesity as cardiovascular risk factors in polycystic ovary syndrome
Uludağ, E. Ü., & Uludağ, E. Ü. (2013) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/diclemedj.0921.2013.03.0303 · Cited by 1
Taponen, S. (2004) · Cited by 1
hOGG1 gene polymorphisms and susceptibility to polycystic ovary syndrome
Xia, Y., Wang, W., Wang, L., Shen, S., Cao, Y., Yi, L., Gao, Q., & Wang, Y. (2016) · Biomedical Reports · doi:10.3892/br.2016.600 · Cited by 1
Caldas, E. L. C., Soares, E. M. M., Araújo, M. E. C., Lemos, M., de Oliveira, T. M., & Azevedo, G. D. (2010) · Cited by 1
C-Reactive Protein Levels in Women with Polycystic Ovarian Syndrome and Healthy Controls
Yılmaz, Ö., Temür, M., Küme, T., Karas, Ç. A., Kelekçi, S., & Öztürk, Y. K. (2017) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.359835 · Cited by 1
EVALUATION OF THE HIGH-SENSITIVITY C-REACTIVE PROTEIN IN YOUNG OBESE WOMEN WITH PCOS
Palo, I., & Mishra, S. K. (2018) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2018/18 · Cited by 1
Popova, P., Baranova, E. V., & Grineva, E. N. (2009) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2009-15-2-218-222 · Cited by 1
Pathogenesis of Polycystic Ovary Syndrome
朱, 海. (2021) · Advances in Clinical Medicine · doi:10.12677/acm.2021.114244 · Cited by 1
Statins, Oxidative Stress, and Polycystic Ovary Syndrome
Kodaman, P. H., & Dulęba, A. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_19 · Cited by 1
Stracquadanio, M., & Ciotta, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-16760-2_3 · Cited by 1
Ring, M. R. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00036-4 · Cited by 1
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.37 · Cited by 1
Wang, Y., Ma, R., Zou, Y., Wang, W., Zheng, Q., Feng, Y., Dong, H., Tan, Z., Zeng, X., Zhao, Y., et al. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2148649 · Cited by 1
Fatima, Q., Jeelani, H., Abass, S., Farooq, M., & Rashid, F. (2023) · Springer eBooks · doi:10.1007/978-981-99-2193-5_9 · Cited by 2
Salma, U., Alshaikh, A. B. A., Alanazi, M. F., Sheikh, M. S. A., & Rashwan, E. K. (2023) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20232268 · Cited by 1
Mariam, S., Mali, A., Khan, S., Agrawal, N., Gupta, J., & Khalique, N. (2023) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_1012_22 · Cited by 1
Gashti, N. G., Hajizadeh, K., Farshbaf‐Khalili, A., Mahdipour, M., & Shahnazi, M. (2025) · International Journal for Vitamin and Nutrition Research · doi:10.31083/ijvnr38965 · Cited by 2
The Risks of Cardiovascular Disease and Diabetes in the Polycystic Ovary Syndrome
Sharma, S. T., & Nestler, J. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-09718-3_10 · Cited by 1
Nabiuni, M., Nasri, S., Poyanmanesh, F., Karimzadeh, L., & Nazari, Z. (2012) · RePEc: Research Papers in Economics · doi:10.5772/intechopen.84084 · Cited by 1
Pattnaik, S., Gupta, S., Saxena, U., Matlani, M., & Kapoor, R. (2021) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_72_2020 · Cited by 1
Çolak, S., & Gürlek, B. (2021) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.38.4.32 · Cited by 1
Síndrome del ovario poliquístico: nuevas perspectivas
Pazos, F., & Rodríguez-Caballero, A. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74657-4 · Cited by 1
THE GENETICS OF INSULIN RESISTANCE IN FAMILIES WITH POLYCYSTIC OVARY SYNDROME
Matar, J. (2006) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Visceral fat and cardiovascular risk in patients with polycystic ovary syndrome
Cascella, T., Palomba, S., Giallauria, F., de Sio, I., Colao, A., Lombardi, G., Orio, M., & Orio, F. (2009) · Clinical Lipidology · doi:10.2217/clp.09.55 · Cited by 1
Pohlmeier, A. M. (2013) · ThinkTech (Texas Tech University) · Cited by 1
de Oliveira, M., & Pereira, M. (2007) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.1590/s0100-72032007000500004
Pasquali, R., & Gambineri, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_4
Polycystic Ovary Syndrome and Cardiovascular Disease
nder, B., Taner, D., Ylmaz, H., & Muzaffer, M. (2012) · InTech eBooks · doi:10.5772/25519
Cribado precoz de diabetes gestacional y macrosomía
Maíz, N., & Plasencia, W. (2014) · Progresos de Obstetricia y Ginecología · doi:10.1016/j.pog.2014.07.009 · Cited by 2
Mitochontrial DNA copy number in peripheral blood in polycystic ovarian syndrome
Lee, J., Lee, S. H., Chung, D. J., Kim, E. S., Ryu, C. S., & Kang, S. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.07.746
Çetinkalp, Ş., Erdoğan, M., Karadeniz, M., Berdelı, A., Tamsel, S., Özgen, G., Saygılı, F., & Yılmaz, C. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903215508
Polycystic ovary syndrome and metabolic syndrome
Hayden, C. J., & Balen, A. H. (2006) · Expert Review of Obstetrics & Gynecology · doi:10.1586/17474108.1.2.183
ez, L. I., Valls, C., & de Zegher, F. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000228702.83347.66
Renke, M. (2009)
Solano, M. E. (2010) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Ülkü, E., Kucur, S. K., Keskin, H., & Kamalak, Z. (2013)
Mohammad, M. A.-A., Olabi, A., & Lahdo, R. (2016) · Innovare Academic Sciences Pvt Ltd - Innovare Journal of Medical Sciences
Serum Procalcitonin and Proinflammatory markers in Polycystic Ovary Syndrome
Göde, F., Yücesoy, F., Sağlam, A., Akarsu, S., Örem, A., & Sharafkhanov, K. (2016) · Gynecology Obstetrics and Reproductive Medicine · doi:10.21613/gorm.2016.619
ORRY, M. M. A.-J. (2017) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2017.8.1.b143-151
Hypertension and Cardiovascular and Lipoprotein Abnormalities in the Polycystic Ovary Snydrome
Orio, F., & Palomba, S. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-179-6_29
Ring, M. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35868-2.00035-9
Shweash, M., HADEED, H. M., FARHAN, Y. M., & Mutar, T. F. (2018) · International Journal of Life Science and Pharma Research · doi:10.22376/ijpbs/lpr.2018.8.3.p1-9
Dikova, N., Karataş, S., Yumru, A. E., Çakmak, B. D., & Türker, Ü. A. (2019) · Journal of Academic Research in Medicine · doi:10.5152/jarem.2019.2309
Sex Differences in Coronary Artery Disease
Kawamoto, K. R., Duvernoy, C. S., & Davis, M. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00012-9
Varghese, D. A., Christy, A. J., Pratheeba, B., Saraswathy, P., & Ravi, D. S. (2019) · International Journal of Innovative Research in Medical Science · doi:10.23958/ijirms/vol04-i09/742
Numbi, D. K., Beya, D. T., Luzolo, G. M., Nyota, P. K., Ngandu, P. C., Ngole, M. Z., Ilunga, G. N., Donatien, K. N.-N., Masidi, J. M., Nkanga, M. N., et al. (2019) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2019.911145
The Effects of Induced Polycystic Ovary Syndrome in NAG-1 Transgenic Mice
Werner, N. (2020) · ScholarWorks (Central Washington University)
Anti sperm Antibody in a Sample of 50 Infertile couples
Areej-A-Jabbar (2011) · Iraqi Journal of Community Medicine
Médicalisation et autonomie des femmes affectées par le syndrome des ovaires polykystiques
Doudenkova, V. (2021) · Canadian Journal of Bioethics · doi:10.7202/1077630ar
Periodontitis and polycystic ovary syndrome: An unveiling review
Bansal, P., Kaur, S., & Mittal, C. (2018) · IP International Journal of Periodontology and Implantology · doi:10.18231/2457-0087.2018.0009
Metadata
- Authors
- Kelly, C. C. J., Lyall, H., Petrie, J. R., Gould, G. W., Connell, J. M. C., & Sattar, N.
- Affiliations
- University of Glasgow (GB)
- Corresponding author
- Sattar, Naveed
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2001-06
- Volume
- 86
- Issue
- 6
- Pages
- 2453-2455
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2168847507
- Cited by
- 640
- References
- 26
- Citations by year
- 2026: 22 · 2025: 26 · 2024: 21 · 2023: 32 · 2022: 25 · 2021: 41 · 2020: 28 · 2019: 22 · 2018: 20 · 2017: 19 · 2016: 20 · 2015: 19 · 2014: 28 · 2013: 21 · 2012: 35
- FWCI
- 18.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- polycystic ovary syndrome, low-grade inflammation, C-reactive protein, insulin resistance, coronary heart disease risk, type 2 diabetes risk, body mass index, hyperinsulinemic-euglycemic clamp, testosterone, women
- MeSH terms
- Adult, C-Reactive Protein, Chronic Disease, Female, Humans, Inflammation, Insulin Resistance, Osmolar Concentration, Polycystic Ovary Syndrome, Reference Values, Sex Hormone-Binding Globulin, Testosterone, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review